Table 2 Survival of anaplastic thyroid cancer patients in subgroups
From: Long-term results of radiotherapy in anaplastic thyroid cancer
Parameter | Subgroups | Median overall survival (months) | p |
|---|---|---|---|
All patients | 5 | ||
Surgery | Yes | 10.5 | 0.02 |
No | 3 | ||
N Stage | N0 | 18.3 | 0.041 |
N+ | 4.5 | ||
M Stage | M0 | 18.3 | 0.07 |
M1 | 4 | ||
Age | <67 years | 5.5 | 0.39 |
≥67 years | 4 | ||
Sex | ♀ | 5 | 0.66 |
♂ | 5 | ||
Histology | “Pure ATC” | 4.5 | 0.29 |
“ATC with PDTC” | 10.5 | ||
Total RT dose (Gy) | ≥50 | 10.5 | 0.02 |
<50 | 3 | ||
Resection status | R2 | 3.6 | 0.41 |
R0, R1 | 12.2 | ||
Lymph node dissection | Yes | 12.2 | 0.051 |
No | 3 | ||
Chemotherapy | Yes | 4 | 0.85 |
No | 5.5 |